Embecta Corp (NAS:EMBC)
$ 14.97 0.43 (2.96%) Market Cap: 863.80 Mil Enterprise Value: 2.20 Bil PE Ratio: 12.48 PB Ratio: 0 GF Score: 28/100

Embecta Corp at Wells Fargo Healthcare Conference Transcript

Sep 08, 2022 / 12:00PM GMT
Release Date Price: $32.43 (+1.28%)
Nathan Treybeck

Hi. Good morning. My name is Nathan Treybeck. I'm on the medical devices team at Wells Fargo. This morning, I'm pleased to have Embecta with us. We have Jake Elguicze, the CFO; and Pravesh Khandelwal, VP and Head of Investor Relations. Thank you for coming.

So Jake, I just wanted to start with the big picture. You're just completing your first stand-alone quarter at Embecta. I appreciate that a lot of work must have gone in to get here today. What attracted you to the position? And what were the biggest surprises as you continue to ramp over the past year or so, both on the positive and negative side?

Jacob P. Elguicze
Embecta Corp. - Senior VP & CFO

Yes, sure, Nate, and thanks very much for having us.

Nathan Treybeck

And I also believe you have a presentation. So we'll start with the presentation and we'll get to the questions. I apologize.

Jacob P. Elguicze
Embecta Corp. - Senior VP & CFO

So good morning, everyone. Good morning, Nate. Thanks for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot